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Thymic malignancies are relatively uncommon, whichmandates that the experience from many different insti-
tutions be combined to achieve a better understanding of the
disease. Nevertheless, this is hampered by many ambiguities
in how results are reported and interpreted. This problem is
aggravated by the fact that smaller institutions often encoun-
ter these tumors only sporadically. A prerequisite to interin-
stitutional collaboration is a common language and consis-
tency in the definition of findings (e.g., whether a complete
resection was accomplished or not).
This article summarizes the policies adopted by the
International Thymic Malignancy Interest Group (ITMIG)
regarding handling of a resection specimen by the surgeon
and pathologist and reporting of the surgical and pathologic
findings. These policies are based as much as possible on
reported evidence, but this is lacking or limited in many
areas. Nevertheless, adoption of a consistent approach is
crucial to conduct valid studies moving forward that can
clarify areas of uncertainty.
This publication addresses only how to handle and
process the tissue specimen at the time of a resection. It does
not address handling and interpretation of biopsies or cyto-
logic specimens, which is an important topic that is addressed
in a separate publication.1 This article is limited to an open
resection (by sternotomy). Although other approaches are
sometimes used (e.g., thoracoscopy), the issues involved are
also covered in another publication.2 Furthermore, this article
is written with the assumption that resection of a thymoma
involves a complete thymectomy along with any adjacent
structures that may be involved and that the goal is a com-
plete (R0) resection (i.e., not debulking).
METHODS
The process used in development of this document was
designed to represent both underlying evidence and a broad
consensus of ITMIG members. An initial workgroup consist-
ing of pathologists and surgeons (Mark Wick, Cesar Moran,
Saul Suster, James Huang, Frank Detterbeck, Garrett Walsh,
and Larry Kaiser) was assembled to review literature relevant
to the issues, existing standards (i.e., the College of Anatomic
Pathologists and the Association of Directors of Anatomic
and Surgical Pathology),3,4 and to discuss technical aspects
and areas in which no prior work was available. This work-
group formulated preliminary recommendations, which were
refined by an extended workgroup (Alexander Marx, Alberto
Marchevsky, William Travis, Andrew Nicholson, Cameron
Wright, Federico Venuta, Paul van Schil, Marco Lucchi,
Meinoshin Okumura, and Kazuya Kondo) and disseminated
to all ITMIG members for further discussion and input. These
recommendations were refined with input from the entire
ITMIG membership and with insights gained from pilot
implementation at several larger centers and ultimately ap-
proved for adoption by the ITMIG members.
RECOMMENDATIONS
Intraoperative Specimen Handling
There are several sources of confusion regarding the
location and margin status in resected thymomas. First is
confusion about orientation of the specimen—once the tissue
is removed from the patient, it can become difficult for
anyone, including the surgeon to correctly orient the speci-
men. Furthermore, during dissection and intraoperative han-
dling, loose areolar tissue can easily be disrupted, thus caus-
ing tissues to appear separated that were not actually
separated originally. Another issue is failure to communicate
areas of concern. It is not obvious to the pathologist, and in
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fact even to the surgeon, exactly where the margin was most
concerning and what part of the operative field in the patient it
corresponds to once the specimen is removed. There is also
often a failure to recognize tissue in the specimen, such as
mediastinal pleura. Although this may look quite distinct in vivo,
because of retraction or minimal trauma, it can become difficult
to recognize grossly and even microscopically. Finally, there are
issues of fragmentation of care resulting in poor communication.
Frequently, the surgeon resects the tumor, which is then pre-
pared by pathology department personnel, and finally interpreted
by a pathologist—none of whom have communicated in detail
with each other about issues of concern (Table 1).
We recommend that the surgeon mark areas of concern on
the specimen immediately at the time this area is dissected to
ensure proper identification of these areas for microscopic ex-
amination. This should be done by placing a stitch in the area of
concern not only through the tissue on the surface that represents
the margin but also through deeper more substantial structures
(if necessary even the tumor itself). This helps prevent tissue
disruption during further handling and dislodgement of the stitch
that can occur if it is placed only through loose areolar tissue. It
is important that stitches are placed immediately on dissecting an
area of concern rather than once the specimen has been com-
pletely removed. At the same time, the corresponding area in the
operative field should be immediately marked with a clip, so it
can be identified at the conclusion of resection or postoperatively
if radiation is indicated. Ideally, marking stitches should be tied
loosely, to make it easier to remove in the gross room after the
margin is inked.
In addition, we recommend that particular “standard”
areas be marked routinely, even if there is no gross concern
about a positive margin. These standard areas include the
surface of the specimen adjacent to the pericardium and
innominate vein and for larger tumors also the superior vena
cava and the right and left pleural surfaces (if these tissues are
not resected). We recommend marking a representative point
on the surface of the specimen adjacent to the innominate
vein and pericardium in every case, whereas marking of
surfaces adjacent to the superior vena cava or the pleura is
suggested but may be impractical in many smaller thymo-
mas. Ideally, the method used for routine marking should
be standardized at an institution, e.g., using black silk for
routine areas and different color sutures for areas of
particular concern.
TABLE 1. Recommended Routine Policies for Surgeons
Marking
Mark areas of concern immediately on dissection, both on the specimen and in the patient
Routinely mark a representative area adjacent to the pericardium and innominate vein (or mark these structures if resected)
Routinely mark right/left mediastinal pleural surfaces (if resected)
Mark a representative area adjacent to the superior vena cava, if the tumor is nearby
Place marking stitches through loose tissue and into more substantial deeper tissue to prevent tissue disruption
Orientation
The surgeon should be involved with orientation of the specimen
The surgeon should either orient the specimen together with the pathologist of use a system of communicating the orientation of the specimen to the
pathologist
Orienting the unfurled specimen on a mediastinal board or diagram is encouraged
A digital photograph of the mounted specimen is encouraged
A sketch of the specimen with adjacent structures and marking stitches is encouraged
Lymph nodes
Any suspicious nodes should be routinely removed in patients with a thymoma
For stage I and stage II thymoma, removal of adjacent nodes and anterior mediastinal nodes is encouraged
For stage III thymoma, a systematic anterior mediastinal node dissection is recommended, and a systematic sampling of appropriate intrathoracic sites
is encouraged (i.e., paratracheal, aortopulmonary window, subcarinal, etc.)
For thymic carcinoma, at least a systematic sampling of anterior mediastinal, intrathoracic, supraclavicular, and lower cervical nodes should be done (if
the diagnosis is suspected or known)
Frozen section
A frozen section for diagnosis should be interpreted cautiously and should be limited to cases with unexpected features or suspected to not be a thymic
malignancy (e.g., lymphoma and germ cell tumor). The clinical diagnosis of thymoma is generally at least as reliable as a frozen section diagnosis
Frozen section determination of adequacy of margins is difficult (high false-negative and false-positive rates); the clinical impression should be
carefully considered, as well as the microscopic impression
Operative note
The operative note should specifically mention the following:
Whether gross tumor was left behind, and if so, where
The extent of resection performed (i.e., complete thymectomy)
The presence and location of any adhesions that were simply divided (not suspicious for involvement)
Any additional structures (i.e., mediastinal pleura, pericardium, phrenic nerve, and innominate vein) or organs removed (i.e., lung)
Any sites of intraoperative concern, including how these were marked on the specimen and in the patient
Which nodal areas were explored and the extent of assessment (i.e., sampling vs. complete dissection)
Whether the pleural and pericardial spaces were (able to be) inspected for metastases
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These procedures should highlight areas of particular
concern and identify representative areas for routine micro-
scopic examination. Nevertheless, there may be areas of the
specimen that appear concerning after the dissection is com-
pleted due to disruption of loose tissue or retraction (but
involved a comfortable margin of normal tissue in situ).
Knowing that these areas were not of concern initially is of
benefit and should be reported in the pathology report as “an
area that was not grossly concerning intraoperatively.” This
requires communication between the surgeon and patholo-
gist, ideally as the specimen is passed off the operative field
or on its arrival in the pathology laboratory. We also recom-
mend that stitches be placed in such areas of tissue disruption
or distortion as soon as this is noticed during the dissection to
minimize further disruption.
Specimen Orientation
The appropriate handling and assessment of the re-
sected specimen begins in the operating room. The proper
orientation of the specimen and the designation of involved
structures, organs, or areas of concern are the primary respon-
sibility of the operating surgeon, as that individual is the only
one with the complete picture of the anatomical relationships
of the specimen in situ and the only one privy to the sites
where close surgical margins may be of concern. To expect a
technician or trainee in the pathology suite to receive an
amorphous specimen in a container and sort out which way is
up, much less recreate the spatial relationships of the medi-
astinum is to invite confusion and uncertainty.
Orienting the specimen on a mediastinal board is sug-
gested (similar to a “neck board” that has become routine to
preserve orientation in head and neck surgery).5 For example,
using a line diagram (Figure 1) of the mediastinum placed on
a simple cork or wax board, the specimen is oriented on the
board, taking care to unfurl the specimen and recreate the
anatomic relationships as best as possible on the diagram
(Figure 2). Involved structures that have been resected with
the specimen en bloc should be identified, and similarly,
margins of clinical concern can be designated (e.g., using
sutures). In this way, the specimen is delivered from the
operating room to the pathology suite with the specimen
oriented as it was in vivo, and attention is drawn to each and
every one of the potential sites of invasion or close margins
that are of clinical relevance. We encourage the use of a
digital photograph of the mounted specimen (Figure 2) or a
sketch of the specimen on a paper diagram of the mediasti-
num (Figure 3) or both and that these be included in the
patient’s medical record (e.g., in the pathology report).
Ideally, the orientation of the specimen should be done
by the surgeon in the operating room but failing that should
be done by the surgeon or their designate in the pathology
suite before grossing. There may be ongoing issues in the
operative field that demand the surgeon’s attention as the
specimen is removed, but if a pathologist receives an un-
marked, unoriented specimen, it is important that he/she
communicates with the surgeon and that they orient and label
the specimen together as soon as the surgeon or a designate
who was present at the resection is available. Sending the
specimen on a mediastinal board, unfurling on a paper dia-
gram, and accompanying the specimen with a sketch are
examples of ways to enhance communication.
We recommend that either a system for orientation be
used (e.g., a mediastinal board) or that the pathologist com-
municates directly with the surgeon in orienting the specimen
(ideally face to face). Sutures or clips should mark attached
structures such as innominate vein, lung, and phrenic nerve
(see previous section). Broader surfaces of concern can be
marked with paint, such as the lateral mediastinal pleura or
the anterior surface of the specimen. It is imperative that the
surgeon enumerate the resected structures in the operative
report, and each area of interest should be itemized on the
accompanying pathology requisition.
Lymph Node Sampling/Dissection
The incidence of lymph node metastases varies accord-
ing to the type of thymic epithelial neoplasm. A survey of
FIGURE 1. Mediastinal board. A diagram on a soft board is
useful in maintaining proper dimensions and orientation of
specimens. Printing this figure as a full page corresponds
roughly to the normal mediastinal dimensions and can be
placed directly on a standard soft specimen board that is
generally available in surgical pathology departments.
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1327 patients from 115 institutes certified as specialized
institutes by the Japanese Association of Chest Surgery found
a 2% (19/1064) incidence of lymph node metastases in
thymoma (0.4% in stage I and 6% in stage III).6 Nevertheless,
it is unclear in this study how often nodes were examined,
and no routine policy seems to have been in place regarding
whether or which nodes were biopsied or dissected. In this
study, multivariate analysis did not find the lymph node status
to be prognostic for thymoma (whereas stage and R0 resec-
tion were independent predictors of survival). Approximately
90% of involved nodes were located in the anterior medias-
tinum and 25% in intrathoracic locations (some patients had
nodes in multiple regions). These results may be confounded
by the extent to which other nodes were evaluated in thy-
moma, and the lack of prognostic significance may be due to
an insufficient sample size.
Nodal metastases are significantly more common
among thymic carcinomas (27%) and thymic carcinoids
(28%), of which approximately 70% and 90% are in the
anterior mediastinum, 35% and 60% in intrathoracic loca-
tions, and 30% and 30% in extrathoracic sites, respectively.6
Multivariate analysis demonstrated that node status and com-
plete resection were the only statistically significant predic-
tors of survival for thymic carcinoma and thymic carcinoids.6
At the time of resection of a thymic malignancy, any
suspicious nodes (e.g., enlarged, firm, or positron emission
tomography avid) should always be removed and separately
labeled and submitted. For apparently encapsulated thymomas,
removal of any adjacent anterior mediastinal nodes is encour-
aged. For thymomas with adjacent organ involvement (stage
III or IVa undergoing curative-intent resection), it is recom-
mended that anterior mediastinal lymph nodes be routinely
removed and submitted, and a systematic sampling of in-
trathoracic sites is encouraged (i.e., paratracheal, aortopulmo-
nary window, subcarinal, etc., depending on tumor location).
This recommendation is based on the relative ease of such
sampling, the appreciable incidence of metastasis, and the
need for more accurate information about nodal metastases.
For thymic carcinoma, we recommend a systematic removal
and separate submission of anterior mediastinal, intratho-
racic, supraclavicular, and lower cervical lymph nodes.
Use of Frozen Section
Use of frozen section to confirm the diagnosis of a
suspected thymoma is difficult and, therefore, should be used
judiciously and interpreted with caution. The difficulty in
interpretation is true in major referral centers and is probably
amplified in institutions with more limited experience. Clin-
ical correlation and feedback from an experienced surgeon
are a valuable adjunct in making the correct diagnosis. The
surgeon must also be sensitive to the fact that small (i.e.,
forceps) biopsies submitted for frozen sections in mediastinal
masses often suffer crush artifact or may not be representative
of the lesion,
The difficulty in interpreting frozen sections of thymo-
mas is particularly manifest in cases rich in lymphocytes,
where it may not be possible to confidently distinguish a
lymphoblastic lymphoma from lymphocyte-rich thymoma
(although the clinical presentation of the former is usually
FIGURE 2. Resected specimen oriented on the mediastinal
board. Placement of the specimen and the paper diagram or
board provides unambiguous orientation, depicts the rela-
tionship to other mediastinal structures, and maintains the
normal size of the resected tissue. Pins placed through the
tissue into the board or paper diagram can be used to hold
it in place if needed.
FIGURE 3. Sketch of the oriented specimen on a mediasti-
nal diagram. The sketch depicts marking stitches and addi-
tional resected structures diagrammatically, which minimizes
subsequent confusion and aids communication.
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rapid and of the latter very indolent). Spindle cell thymomas
can be often confused with other spindle cell tumors occur-
ring in the mediastinum, such as solitary fibrous tumor,
synovial sarcoma, and others. Separation of atypical thy-
moma (World Health Organization type B3) and well-differ-
entiated squamous cell thymic carcinoma may be also very
difficult to establish on frozen sections and may require
deferring to permanents.7 The surgeon should also be aware
of the fact that pathologists are unable to distinguish mor-
phologically between a primary thymic carcinoma and a
metastasis of a carcinoma from another source. Cystic tumors
may be particularly difficult to evaluate on frozen sections
because the fibrosing and inflammatory process that often
accompanies cystic changes in the thymus can obscure an
underlying malignancy.
Luckily, in the majority of instances, frozen sections
are not required in the course of thymoma surgery to confirm
the diagnosis; usually, a clinical diagnosis can be made
reliably or established preoperatively (e.g., cytology and core
biopsy) when there is uncertainty. Use of frozen sections in
the evaluation of thymoma and other mediastinal tumors can
occur in the setting of a tumor discovered incidentally during
the course of open chest surgery for other reasons (i.e., during
coronary artery bypass surgery) or to determine whether an
incisional biopsy of a nonresectable mediastinal mass con-
tains adequate diagnostic tissue. Frozen section examination
may be of value in circumstances in which the surgeon finds
a tumor showing gross features that are not typical of thy-
moma (i.e., more extensive infiltration than anticipated, areas
of necrosis, or areas of the tumor that look atypical).
Frozen sections can be of benefit to the surgeon to
assess the adequacy of the margins when undertaking a
complete resection of an invasive tumor. Nevertheless, these
are also very difficult for the pathologist to interpret. The
surgeon must be aware that there is general agreement that
the frequency of false-positive or false-negative frozen sec-
tion interpretations is fairly high, although accurate definition
of these values is not available. The clinical judgment of an
experienced surgeon cannot necessarily be replaced by frozen
section assessment.
Gross Preparation of Excised Specimens
In handling the unfixed specimen, its anterior, poste-
rior, and right and left aspects should be specifically identi-
fied (one way is with indelible inks of different colors Figures
4A, B).4 This should be done in the gross pathology labora-
tory after the anatomic landmarks of the tissue have been
established. It is critical that any ambiguities be resolved by
direct communication between the surgeon (or designee who
was present during resection) and the pathologist (or desig-
nee) before pathologic processing.
Once the different anatomical aspects and landmarks
have been identified and the tumor mass inked, we suggest
that the tumor be cut in a bread-loafing manner from superior
to inferior in thin sections (Figure 5). We suggest cutting
from anterior through the posterior aspect of the tumor in a
circumferential fashion exposing the entire circumference of
the tumor. Each section should be placed in order in the
corresponding cassettes properly labeled using letters or num-
bers for paraffin embedding and further histological evalua-
tion. Clear identification of different aspects of the specimen
(e.g., with different ink colors) and orderly submitted sections
allows the exact area of a positive or close margin, if present,
to be easily determined. Random sections of the uninvolved
specimen should also be routinely taken, Figure 6.
Thymomas are well known for their potential micro-
scopic heterogeneity,8 such that different areas of the lesion
may well have very dissimilar histological appearances. A
common policy in surgical pathology is to submit at least one
block of tissue for each centimeter of maximal tumor dimen-
sion (i.e., a 10 cm lesion would require 10 blocks, a 5 cm
lesion 5 blocks, etc.).3,4 This approach has been used suc-
FIGURE 4. A, Inked specimen,
anterior aspect. Blue ink labels the
anterior aspect and yellow ink the
right lateral aspect of the tumor
(on the left side of the photo-
graph). B, Inked specimen, poste-
rior aspect. The posterior aspect of
the specimen has been inked with
black ink. Note the yellow ink la-
beling the right lateral aspect of
the tumor on the right side of the
figure.
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cessfully in evaluating other histologically variable neo-
plasms, such as germ cell tumors and soft tissue sarco-
mas.9–12 Moreover, past publications have shown that
systematic tissue sampling with at least five sections im-
proves the reliability of the pathologic characterization of
thymic epithelial tumors,8,13 and at least five sections are
recommended by the Association of Directors of Anatomic
and Surgical Pathology.4
If a thymic neoplasm is quite small, it can usually be
submitted completely for microscopy in only two or three
blocks. At least five blocks should be obtained from tumors
that are more than 5 cm.8
Banking tissue for future research is critical for advanc-
ing our understanding of the biology of these tumors. Tissue
banking should ideally be undertaken by the pathologist in
charge of the case to balance the need for adequate diagnostic
tissue while maximizing tissue preservation for research and
molecular characterization. Banking of tissue for research can
generally be easily accomplished in most cases of thymic
tumors because of the large size of the specimens. For most
large specimens, 1 cm3 of viable tumor tissue can be sampled,
snap-frozen, labeled, and stored in a deep freezer and subse-
quently aliquoted for various uses. A parallel 3-mm-thick
section from the underlying contiguous tissue should be
submitted in formalin for regular histologic processing and
paraffin embedding to serve as a control or for studies
involving techniques that can be performed in formalin-fixed,
paraffin-embedded tissues.
The particular selection of areas of the lesion that are
sampled will depend on careful macroscopic assessment by
the pathologist, together with pertinent information from the
surgeon. All surfaces of the specimen should be routinely
examined macroscopically. Certainly, any areas identified by
either the surgeon or the pathologist as possibly being an
involved margin must be sampled. Furthermore, any areas
with a gross appearance that clearly diverges from the re-
mainder of the tumor should be sampled. Cases have been
well described in which fundamentally different diagnostic
entities were coexistent in a specimen (e.g., a thymic carci-
noma within yet distinct from a “parent” thymoma).14
A special subgroup of thymomas are extensively—and
sometimes completely—cystic.15–17 This may occur sponta-
neously (perhaps due to poor blood supply) or iatrogenically
(after preoperative chemotherapy).18,19 The pathologist must
sample the periphery of the cyst extensively to obtain diag-
nostically dispositive tissue, especially if no preresection
biopsy was obtained. This is necessary to exclude other
possible cystic neoplasms of the thymic region, such as germ
cell tumors, metastatic carcinomas, and rare examples of
malignant lymphoma.17
Reporting of Microscopic Findings
Invasion
The final pathological diagnosis of each specimen
should include whether the tumor is invasive. We suggest the
use of the designation localized, minimally invasive, or in-
vasive (Table 2). Penetrations within the capsule do not
render the tumor invasive, and such tumors should also be
FIGURE 5. Bread-loafed tumor specimen. The tumor mass
has been sectioned from superior to inferior in a bread-loaf
manner into thin sections. This is useful to document spe-
cific gross features and to identify specific areas that may
require special attention and histopathological assessment.
Note that the different colors are easily identifiable.
FIGURE 6. Remaining uninvolved thymic tissue. Random
sections of this tissue should be obtained for histopathologi-
cal assessment.
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designated as thymoma, localized. The tumor must breach the
capsule to be designated as invasive. Tumors in which there
is only microscopic invasion of a few millimeters (i.e., 3
mm) beyond the capsule into the surrounding fat but with no
compromise of the inked outer surface of the specimen or of
surrounding structures should be designated as thymoma,
minimally invasive. Although the clinical implication of
distinguishing between a noninvasive and minimally invasive
tumor is unclear, this three-tiered definition is consistent with
the official recommendations in effect at this time.4,20 Fur-
thermore, ambiguity in the definition of noninvasive and
minimally invasive tumors in past publications makes inter-
pretation of previous publications difficult and demands pro-
spective study using consistent and more clearly articulated
definitions.
Also important is to document whether the tumor has a
fibrous capsule. It should be recognized that the capsule is
a reflection of desmoplasia induced by the tumor and not a
native anatomical landmark. In some cases, the fibrous cap-
sule may be either absent or only partially surround the
tumor. A tumor in which the fibrous capsule is missing in
some areas should have this clearly documented in the report
(i.e., thymoma, partially unencapsulated), and it should be
indicated in a note that capsular invasion cannot be assessed
in the areas devoid of a capsule. Care should be taken not to
interpret the point at which the tumor interfaces with the
surrounding mediastinal fat as evidence of invasion in an
unencapsulated thymoma. The pathologist should record
whether the areas devoid of a capsule reach up to the inked
margins of the specimen (this would not affect the classifi-
cation of invasion but would be designated as a positive
margin).
It is difficult to differentiate between tumor that is
densely adherent to the pleura or pericardium, partial inva-
sion of the mediastinal pleura or pericardium, and penetration
of these structures. We recommend that these situations be
distinguished, as best as possible. Details are described in a
separate article.20 We recommend that tumor that is adherent
to the structure but not invading it, according to the best
judgment of the pathologist, be classified as “tumor adherent
to but not invading” the mediastinal pleura or pericardium.
The implications of how these definitions affect the stage
TABLE 2. Recommended Routine Policies for Pathologists
Gross preparation of the excised specimen
Resolution of ambiguities by communication between the surgical and pathological team immediately at the time of resection
Identify areas of concern before sectioning
Identify areas of tissue disruption that occurred during handling
Anterior, posterior, right, and left surfaces should be clearly distinguished (e.g., inked with different colors or with a detailed block key)
Tumor bread loafed (e.g., from superior to inferior) with sections serially ordered and submitted
One block per cm of tumor should be submitted
At least five representative sections should be taken regardless of the tumor diameter
Random sections from the remaining uninvolved thymus should be submitted
As much tissue as possible should be banked without compromising the diagnostic assessment; adjacent sections in paraffin should be taken for
comparison
Reporting policies for margins
Capsular integrity and invasion
Thymoma, localized (encapsulated, although capsule may be partially absent)
Thymoma, minimally invasive (penetration through capsule but only minimally into adjacent fat, i.e., 3 mm)
Thymoma, invasive (with infiltration of surrounding structures including mediastinal fat)
Margin status
Negative
Intact normal tissue overlying the tumor, or
Invasion of structures bounded by a space (i.e., pleura or pericardium) or
Inked outer surface of specimen consisting of intact capsule, or
Tumor extending up to inked margin in an area of tissue disruption that was identified as not grossly concerning intraoperatively (with additional
text identifying this situation)
Positive (tumor extending to an inked surgically cut margin)
Distance to closest margin
Distance in mm reported whenever 3 mm
If  1 mm (or 1 hpf) at least three additional levels should be examined
Processing and reporting policies after neoadjuvant therapy
Gross preparation should follow the same principles as a primarily resected specimen
At least five representative sections should be taken regardless of the tumor diameter
At least one block per cm of tumor should be submitted
Careful sampling is required according to the policies defined for a primary specimen before a complete pathologic response can be defined
The percent of viable tumor (in 10% increments) should be reported based on an aggregate assessment of multiple representative sections of the
resected tumor
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classification are addressed elsewhere20; this article merely
addresses the terminology of microscopic findings.
Margin Status
In defining the status of margins, it is important to make
a distinction between tissues that have been cut or dissected
and a surface bounded by a space (such as the mediastinal
pleura, pericardium, or endothelium of the innominate veins
or superior vena cava). Tumor extending to the mediastinal
pleural or pericardial surface that is bounded by a space
should not be designated as a positive margin. Areas of tumor
extending beyond such a space into additional adjacent tis-
sues (e.g., lung) should be designated as a negative margin if
tumor does not extend up to the inked margin of the adjacent
tissue and positive if it does.
A source of difficulty in thymic malignancies is the fact
that often there is little tissue surrounding the tumor and that this
tissue is loose areolar tissue that retracts to a minimal thickness
and is easily artificially disrupted. Nevertheless, loose areolar
tissue that has been surgically divided technically constitutes
a surgical margin. A frequent source of misleading interpre-
tations of the margin is a casual assessment of such areas
where there is minimal tissue surrounding the tumor. Any
areas of dissection that are potentially of concern should be
specifically tagged and designated by the surgeon as de-
scribed previously in this article. The presence of ink on the
outer surface of the specimen, if seen only on the capsule or a
thin layer of areolar tissue but not in contact with the actual
tumor, should not be regarded as a positive margin. Quite often,
the capsule in thymoma constitutes the outer surface of the
specimen. In such cases only through-and-thorough penetration
of the capsule by tumor which reaches the inked outer surface
should be interpreted as a positive margin.
In all situations in which the margin is close (i.e., 3
mm), the distance separating the tumor from the closest inked
margin of resection should be documented. Furthermore, if
the margin is 1 mm, we recommend that at least three
additional levels through this area should be obtained and
noted in the report, as it is likely that examination of several
levels may reveal an area of a positive margin. Reporting a
positive or close margin should include definition of which
aspect of the specimen is involved. The use of different colors
of ink should facilitate this, combined with the clear orien-
tation and intraoperative marking of areas of concern with
stitches as described in preceding sections of this article. Any
areas of concern identified and marked by the surgeon should
be specifically investigated and reported.
Special mention must be made regarding reporting of
areas that were not grossly concerning intraoperatively but in
which tissue disruption was noted to have occurred (and were
identified and marked as such). These areas should be de-
scribed according to the policies outlined in the preceding
paragraphs with respect to extension to the margin of the
specimen or closest distance to the margin. Nevertheless, if
exposed tumor is seen in an area that was clearly identified as
one that was not grossly concerning but in which tissue
disruption occurred, it should be classified as a negative
together with further clarification, e.g., “negative, not initially
grossly concerning, but with tissue disruption up to (or close
to) the tumor.”
Reporting of Results After Neoadjuvant
Therapy
Gross preparation of a resected specimen after preop-
erative (neoadjuvant) therapy should follow the same princi-
ples outlined for primarily resected specimens, and prepara-
tion and reporting of the margin status should also be the
same. Nevertheless, it is likely that some of the tumor will
have become necrotic. Therefore, the policies proposed for
primary resection should represent a minimum, and it is
likely that in many cases more sections will need to be
examined to have a valid representation of the histologic
appearance. Tissue banking is still encouraged but may be
less feasible and less appropriate for many studies for several
reasons. The tumor characteristics may have been altered by
the neoadjuvant therapy, and interpretation of the finding is
likely to be difficult unless there is a banked preinduction
therapy sample for comparison.
In those cases where neoadjuvant therapy has caused
cystic degeneration of the mass, the cross-sectional percent-
age of remaining viable tumor should be reported. The
percentage of viable tumor should be estimated grossly from
examination of the sectioned specimen laid out sequentially
on the cutting board and the estimated percentage entered into
the gross description. The presumed viable portions of the
tumor must be entirely sampled for histologic examination
and marked on a diagram or a digital photograph of the
specimen. These areas should then be correlated with the
histologic sections to further adjust the true percentage of viable
tumor tissue. Preoperative radiation or chemotherapy will gen-
erally result in shrinkage and disappearance of the tumor with
replacement by fibrous connective tissue.21 Histological exami-
nation is the only way to assess the extent of viable tumor in
such cases. We do not recommend that any procedures other
than the policies described in this article be done to determine
whether there is a pathologic complete response.
DISCUSSION
The recommended procedures and policies for report-
ing findings for surgical resection of thymomas proposed in
this article represent a consensus adopted by the ITMIG. This
organization includes the majority of physicians and health
care workers with a particular interest in this disease. These
proposed policies should prevent some of the ambiguities in
past publications that have made comparison of institutional
series difficult.
The proposed policies are based on data whenever
possible. Where this is not available, an approach was taken
that matches or is similar to what is already in use either for
thymic malignancies3,4 or in the classification of tumors in
general. Nevertheless, there are also instances in which the
proposed policies simply follow a logical approach because
no previous work is available to draw on.
These proposed policies will be used in the formal
initiatives of the ITMIG organization (e.g., the international
database and collaborative research projects). These policies
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should also be voluntarily used by ITMIG members. Further-
more, these measures will serve as a basis for the thymic
malignancy staging project being undertaken by the Interna-
tional Staging Committee of the International Association for
the Study of Lung Cancer.
Key measures to focus on are whether the system imple-
mented by centers reliably allows determination of a positive or
negative margin, how well one can identify where the positive
margin is located in the patient (for adjuvant radiotherapy), and
whether this impacts local recurrence rates.
These policies are meant to encourage individual re-
search into their validity. Furthermore, exploration of other
surgical and pathologic characteristics or approaches in ad-
dition to the policies proposed in this study is encouraged. It
is recognized that these policies represent only a step in the
process of developing more scientifically robust means of
addressing issues with respect to thymic malignancies. It is
fully expected that modifications or alterations of these pol-
icies will be developed and adopted over time.
CONCLUSION
These recommendations represent a broad consensus
about policies that should be adopted by surgeons and pa-
thologists in handling and processing thymic tissue speci-
mens. It is recognized that some of the recommendations are
based on prior research, whereas others are based on rational
thought that has not been tested. Widespread adoption of
these policies should allow more uniform data collection and
facilitate research that can refine the policies in the future.
Adherence to a particular approach until this is available is
necessary to collect more accurate data regarding not only
reporting of pathology results but also to inform questions
about staging and treatment of thymic malignancies.
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